Photo taken from: FDA Oncology/X
Mar 24, 2024, 23:14
FDA Oncology: FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues
FDA Oncology recently shared a post on X:
“FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues in this episode of The Uromigos podcast.”
Source: FDA Oncology/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32